Your browser doesn't support javascript.
loading
Premature aging and cancer development in transgenic mice lacking functional CYLD.
Alameda, Josefa P; Ramírez, Ángel; García-Fernández, Rosa A; Navarro, Manuel; Page, Angustias; Segovia, José C; Sanchez, Rebeca; Suárez-Cabrera, Cristian; Paramio, Jesús M; Bravo, Ana; Fernández-Aceñero, M Jesús; Casanova, M Llanos.
Afiliação
  • Alameda JP; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/CIBERONC, Madrid 28040, Spain.
  • Ramírez Á; Biomedical Research Institute I+12, 12 de Octubre University Hospital, Madrid 28040, Spain.
  • García-Fernández RA; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/CIBERONC, Madrid 28040, Spain.
  • Navarro M; Biomedical Research Institute I+12, 12 de Octubre University Hospital, Madrid 28040, Spain.
  • Page A; Department of Animal Medicine and Surgery, Faculty of Veterinary, UCM, Madrid 28040, Spain.
  • Segovia JC; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/CIBERONC, Madrid 28040, Spain.
  • Sanchez R; Biomedical Research Institute I+12, 12 de Octubre University Hospital, Madrid 28040, Spain.
  • Suárez-Cabrera C; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/CIBERONC, Madrid 28040, Spain.
  • Paramio JM; Biomedical Research Institute I+12, 12 de Octubre University Hospital, Madrid 28040, Spain.
  • Bravo A; Division of Hematopoietic Innovative Therapies, CIEMAT/CIBERER/II-FJD, Madrid 28040, Spain.
  • Fernández-Aceñero MJ; Division of Hematopoietic Innovative Therapies, CIEMAT/CIBERER/II-FJD, Madrid 28040, Spain.
  • Casanova ML; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)/CIBERONC, Madrid 28040, Spain.
Aging (Albany NY) ; 11(1): 127-159, 2019 01 10.
Article em En | MEDLINE | ID: mdl-30631004
ABSTRACT
CYLD is a deubiquitinating enzyme known for its role as a tumor suppressor whose mutation leads to skin appendages tumors and other cancers. In this manuscript we report that the tumor suppressor CYLD, similarly to other renowned tumor suppressor genes, protects from premature aging and cancer. We have generated transgenic mice expressing the mutant CYLDC/S protein, lacking its deubiquitinase function, under the control of the keratin 5 promoter, the K5-CYLDC/S mice. These mice express the transgene in different organs, including those considered to be more susceptible to aging, such as skin and thymus. Our results show that K5-CYLDC/S mice exhibit epidermal, hair follicle, and sebaceous gland alterations; and, importantly, they show signs of premature aging from an early age. Typically, 3-month-old K5-CYLDC/S mice exhibit a phenotype characterized by alopecia and kyphosis, and, the histological examination reveals that transgenic mice show signs of accelerated aging in numerous organs such as skin, thymus, pancreas, liver and lung. Additionally, they spontaneously develop tumors of diverse origin. Over-activation of the NF-κB pathway, along with hyperactivation of Akt, JNK and c-Myc, and chronic inflammation, appear as the mechanisms responsible for the premature aging of the K5-CYLDC/S mice.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Folículo Piloso / Senilidade Prematura / Enzima Desubiquitinante CYLD / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Folículo Piloso / Senilidade Prematura / Enzima Desubiquitinante CYLD / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article